Skip to main content
Erschienen in: European Journal of Nutrition 2/2020

29.06.2019 | Review

The effect of probiotics, prebiotics, and synbiotics on hormonal and inflammatory indices in women with polycystic ovary syndrome: a systematic review and meta-analysis

verfasst von: Sevda Gholizadeh Shamasbi, Solmaz Ghanbari-Homayi, Mojgan Mirghafourvand

Erschienen in: European Journal of Nutrition | Ausgabe 2/2020

Einloggen, um Zugang zu erhalten

Abstract

Introduction

Polycystic ovary syndrome (PCOS) is among the most prevalent endocrine disorders in women and can lead to many other disorders and chronic diseases. Thus, early diagnosis and treatment of this syndrome is important. Using probiotics, prebiotics, and synbiotics supplementations to treat PCOS seems appropriate because of their useful effects and low complications.

Aims

To assess the effects of probiotics, prebiotics, and synbiotics on hormonal indices such as testosterone, dehydroepiandrosterone sulfate (DHEA-S), sex hormone binding globulin, Free Androgen Index (FAI), and inflammatory indices, such as high sensitive C reactive protein (hsCRP), malondialdehyde (MDA), total glutathione (GSH), nitric oxide (NO), and total antioxidant capacity (TAC) as the primary outcomes and the hirsutism score as the secondary outcome.

Methods

All published articles from the beginning until 10 November 2018 in English (Cochrane Library, Web of Sciences, Google Scholar, PubMed, Scopus, and ProQuest) and Persian (SID and Magiran) databases were searched. The effect of interventions on the outcomes was reported with a standard mean difference (SMD) and confidence interval of 95%. In case of high heterogeneity, the random effect model was used instead of the fixed effect model. The statistical heterogeneity of the included clinical trials was tested using the Chi square test and I2.

Results

Thirteen studies with 855 participants with PCOS(438 women in the intervention group and 417 women in the control group) were included in the meta-analysis. Results of the meta-analysis showed that the SHBG (SMD: 0.56; 95% CI 0.26–0.86; P = 0.0002) and NO (SMD: 0.38; 95% CI 0.09–0.68; P = 0.01) concentration increased significantly in the probiotics and synbiotics groups compared to the placebo group. FAI (SMD: − 0.58; 95% CI − 0.95 to − 0.21; P = 0.002) and MDA (SMD: − 0.76; 95% CI − 1.46 to − 0.05; P = 0.03) concentration in the probiotics and synbiotics groups reduced significantly compared to the placebo group. The results of meta-analyses on other hormonal and inflammatory indices such as testosterone, DHEAS, GSH, hsCRP, TAC, and hirsutism score showed that there were no significant differences between the intervention and control groups.

Conclusion

Using synbiotics and probiotics in women with polycystic ovary syndrome improve hormonal (FAI, SHBG) and inflammatory (NO, MDA) indices in these patients.
Literatur
1.
Zurück zum Zitat Aalei Bibi SH, Naderi T (2004) Poly cystic ovarian syndrome: clinical, ultrasound and laboratory characteristics, Kerman. Iran J Endocrinol Metab 6(2):153–161 Aalei Bibi SH, Naderi T (2004) Poly cystic ovarian syndrome: clinical, ultrasound and laboratory characteristics, Kerman. Iran J Endocrinol Metab 6(2):153–161
2.
Zurück zum Zitat Speroff L, Mark AF (2011) Clinical gynecology endocrinology and infertility, 8th edn. Lippincott Williams & Wilkins, Philadelphia Speroff L, Mark AF (2011) Clinical gynecology endocrinology and infertility, 8th edn. Lippincott Williams & Wilkins, Philadelphia
3.
Zurück zum Zitat Nadjarzadeh A, Dehghani Firouzabadi R, Vaziri N, Daneshbodi H, Lotfi MH, Mozaffari-Khosrav H (2013) The effect of omega-3 supplementation on androgen profile and menstrual status in women with polycystic ovary syndrome: a randomized clinical trial. Iran J Reprod Med 11(8):665–672PubMedPubMedCentral Nadjarzadeh A, Dehghani Firouzabadi R, Vaziri N, Daneshbodi H, Lotfi MH, Mozaffari-Khosrav H (2013) The effect of omega-3 supplementation on androgen profile and menstrual status in women with polycystic ovary syndrome: a randomized clinical trial. Iran J Reprod Med 11(8):665–672PubMedPubMedCentral
5.
Zurück zum Zitat Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group (2004) Revised 2003 Consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 81(1):19–25 Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group (2004) Revised 2003 Consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 81(1):19–25
6.
Zurück zum Zitat Mehrabian F, Khani B, Kelishadi R, Ghanbari E (2011) The prevalence of poly cystic ovary syndrome in Iranian women based on different diagnostic criteria. EndoCrynol Polska 62(3):238–242 Mehrabian F, Khani B, Kelishadi R, Ghanbari E (2011) The prevalence of poly cystic ovary syndrome in Iranian women based on different diagnostic criteria. EndoCrynol Polska 62(3):238–242
7.
Zurück zum Zitat Kauffman RP, Baker VM, Dimarino P, Castracane VD (2002) Poly cystic ovarian syndrome and insulin resistance in white and Mexican American women: a comparison of two distinct population. An J Obstet Gynecol 187(5):1362–1369 Kauffman RP, Baker VM, Dimarino P, Castracane VD (2002) Poly cystic ovarian syndrome and insulin resistance in white and Mexican American women: a comparison of two distinct population. An J Obstet Gynecol 187(5):1362–1369
8.
Zurück zum Zitat Koivunen R, Laatikainen T, Tomas C, Huhtaniemi I, Tapanainen J, Martikainen H (1999) The prevalence of poly cystic ovaries in healthy women. Acta Obstet Gynecol Scand 78(2):137–141PubMed Koivunen R, Laatikainen T, Tomas C, Huhtaniemi I, Tapanainen J, Martikainen H (1999) The prevalence of poly cystic ovaries in healthy women. Acta Obstet Gynecol Scand 78(2):137–141PubMed
9.
10.
Zurück zum Zitat Moran LJ, Ranasinha S, Zoungas S, McNaughton SA, Brown WJ, Teede HJ (2013) The contribution of diet, physical activity and sedentary behaviour to body mass index in women with and without polycystic ovary syndrome. Hum Reprod 28(8):2276–2283PubMed Moran LJ, Ranasinha S, Zoungas S, McNaughton SA, Brown WJ, Teede HJ (2013) The contribution of diet, physical activity and sedentary behaviour to body mass index in women with and without polycystic ovary syndrome. Hum Reprod 28(8):2276–2283PubMed
11.
Zurück zum Zitat Bizzarri M, Carlomagno G (2014) Inositol: history of effective therapy for polycystic ovary syndrome. Eur Rev Med Pharmacol Sci 18:1896–1903PubMed Bizzarri M, Carlomagno G (2014) Inositol: history of effective therapy for polycystic ovary syndrome. Eur Rev Med Pharmacol Sci 18:1896–1903PubMed
12.
Zurück zum Zitat Chittenden BG, Fullerton G, Maheshwari A, Bhattacharya S (2009) Polycystic ovary syndrome and the risk of gynaecological cancer: a systematic review. Reprod Biomed Online 19(3):398–405PubMed Chittenden BG, Fullerton G, Maheshwari A, Bhattacharya S (2009) Polycystic ovary syndrome and the risk of gynaecological cancer: a systematic review. Reprod Biomed Online 19(3):398–405PubMed
13.
Zurück zum Zitat Meyer C, McGrath BP, Teede HJ (2005) Overweight women with polycystic ovary syndrome have evidence of subclinical cardiovascular disease. J Clin Endocrinol Metab 90(10):5711–5716PubMed Meyer C, McGrath BP, Teede HJ (2005) Overweight women with polycystic ovary syndrome have evidence of subclinical cardiovascular disease. J Clin Endocrinol Metab 90(10):5711–5716PubMed
14.
Zurück zum Zitat Lobo RA (2001) Priorities in polycystic ovary syndrome. Med J Aust 174:554–555PubMed Lobo RA (2001) Priorities in polycystic ovary syndrome. Med J Aust 174:554–555PubMed
16.
Zurück zum Zitat Salehpour S, Taherzadeh Broujeni P, Neisani Samani E (2008) Leptin, ghrelin, adiponectin, homocysteine and insulin resistance related to polycystic ovary syndrome. Int J Fertil Steril 2(3):101–104 Salehpour S, Taherzadeh Broujeni P, Neisani Samani E (2008) Leptin, ghrelin, adiponectin, homocysteine and insulin resistance related to polycystic ovary syndrome. Int J Fertil Steril 2(3):101–104
17.
Zurück zum Zitat Hoftman BH, Bradshaw KD, Cunningham FG, Halvorson LM, Schaffer JI, Schorge JO (2008) Williams gynecology. Mc Graw-Hill Medical, New York Hoftman BH, Bradshaw KD, Cunningham FG, Halvorson LM, Schaffer JI, Schorge JO (2008) Williams gynecology. Mc Graw-Hill Medical, New York
19.
Zurück zum Zitat Schrezenmeir J, De Vaese M (2001) Probiotics, prebiotics, and synbiotics-approaching a definition. J Nutr 73:361–364 Schrezenmeir J, De Vaese M (2001) Probiotics, prebiotics, and synbiotics-approaching a definition. J Nutr 73:361–364
20.
Zurück zum Zitat Scavuzzi BM, Hernique FC, Miglioranza LHS, Sinmao ANC, Dichi I (2014) Impact of prebiotics, probiotics and synbioticss on components of the metabolic syndrome. Ann Nutr Disord Ther 1(2):1009 (ISSN: 2381-8891) Scavuzzi BM, Hernique FC, Miglioranza LHS, Sinmao ANC, Dichi I (2014) Impact of prebiotics, probiotics and synbioticss on components of the metabolic syndrome. Ann Nutr Disord Ther 1(2):1009 (ISSN: 2381-8891)
21.
Zurück zum Zitat Roberfroid B, Bornet F, Bouley C, Cummings JH (1995) Colonic microflora:nutrition and health: summary and conclusions of an International Life Sciences Institute (ILSI) [Europe] workshop held in Barcelona, Spain. Nutr Rev 53(5):127–130PubMed Roberfroid B, Bornet F, Bouley C, Cummings JH (1995) Colonic microflora:nutrition and health: summary and conclusions of an International Life Sciences Institute (ILSI) [Europe] workshop held in Barcelona, Spain. Nutr Rev 53(5):127–130PubMed
22.
Zurück zum Zitat Paineau D, Payen F, Panserieu S, Coulombier G, Sobaszek A, Lartigau I et al (2008) The effects of regular consumption of short-chain fructo-oligosaccharides on digestive comfort of subjects with minor functional bowel disorders. Br J Nutr 99(2):311–318PubMed Paineau D, Payen F, Panserieu S, Coulombier G, Sobaszek A, Lartigau I et al (2008) The effects of regular consumption of short-chain fructo-oligosaccharides on digestive comfort of subjects with minor functional bowel disorders. Br J Nutr 99(2):311–318PubMed
24.
Zurück zum Zitat Scholz-Ahrens KE, Schrezenmeir JR (2007) Inulin and oligofructose and mineral metabolism: the evidence from animal trials. J Nutr 137(11):2513S–2523SPubMed Scholz-Ahrens KE, Schrezenmeir JR (2007) Inulin and oligofructose and mineral metabolism: the evidence from animal trials. J Nutr 137(11):2513S–2523SPubMed
25.
Zurück zum Zitat Scavuzzi BM, Hernique FC, Miglioranza LHS, Sinmao ANC, Dichi I (2014) Impact of prebiotics, probiotics and synbioticss on components of the metabolic syndrome. Ann Nutr Disord and Ther 1(2):1009 (ISSN: 2381-8891) Scavuzzi BM, Hernique FC, Miglioranza LHS, Sinmao ANC, Dichi I (2014) Impact of prebiotics, probiotics and synbioticss on components of the metabolic syndrome. Ann Nutr Disord and Ther 1(2):1009 (ISSN: 2381-8891)
26.
Zurück zum Zitat Greg Kelly N (2009) Inulin-type prebiotics: review (part2). Altern Med Rev 14(1):36–55PubMed Greg Kelly N (2009) Inulin-type prebiotics: review (part2). Altern Med Rev 14(1):36–55PubMed
27.
Zurück zum Zitat Homayouni Rad A (2008) Therapeutical effects of functional probiotic, prebiotic and synbiotics foods, 1st edn. Tabriz University of Medical Sciences, Tabriz Homayouni Rad A (2008) Therapeutical effects of functional probiotic, prebiotic and synbiotics foods, 1st edn. Tabriz University of Medical Sciences, Tabriz
28.
Zurück zum Zitat Goldin BR, Gorbach SL (2008) Clinical indications for probiotics: an overview. Clin Infect Dis 46(2):96–100 Goldin BR, Gorbach SL (2008) Clinical indications for probiotics: an overview. Clin Infect Dis 46(2):96–100
29.
Zurück zum Zitat Begley M, Hill C, Gahan CGM (2006) Bile salt hydrolase activity in probiotics. Appl Environ Microbiol 72(3):1729–1738PubMedPubMedCentral Begley M, Hill C, Gahan CGM (2006) Bile salt hydrolase activity in probiotics. Appl Environ Microbiol 72(3):1729–1738PubMedPubMedCentral
30.
Zurück zum Zitat Oelschlaeger T (2010) Mechanisms of probiotic actions—a review. Int J Med Microbiol 300(1):57–62PubMed Oelschlaeger T (2010) Mechanisms of probiotic actions—a review. Int J Med Microbiol 300(1):57–62PubMed
31.
Zurück zum Zitat Flint H, Bayer E, Rincon M, Lamed R, White B (2008) Polysaccharide utilization by gut bacteria: potential for new insights from genomic analysis. Nat Rev Microbiol 6(2):121–131PubMed Flint H, Bayer E, Rincon M, Lamed R, White B (2008) Polysaccharide utilization by gut bacteria: potential for new insights from genomic analysis. Nat Rev Microbiol 6(2):121–131PubMed
32.
Zurück zum Zitat Gibson GR, Roberfroid MB (1995) Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics. J Nutr 125(6):1401–1412PubMed Gibson GR, Roberfroid MB (1995) Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics. J Nutr 125(6):1401–1412PubMed
33.
Zurück zum Zitat Fooks LJ, Gibson GR (2002) Probiotics as modulators of the gut flora. Br J Nutr 88(1):S39–S49PubMed Fooks LJ, Gibson GR (2002) Probiotics as modulators of the gut flora. Br J Nutr 88(1):S39–S49PubMed
34.
Zurück zum Zitat Su P, Henriksson A, Mitchell H (2007) Prebiotics enhance survival and prolong the retention period of specific probiotic inocula in an in vivo murine model. J Appl Microbiol 103(6):2392–2400PubMed Su P, Henriksson A, Mitchell H (2007) Prebiotics enhance survival and prolong the retention period of specific probiotic inocula in an in vivo murine model. J Appl Microbiol 103(6):2392–2400PubMed
35.
Zurück zum Zitat Karamali M, Eghbalpour S, Rajabi S, Jamilian M et al (2018) Effects of probiotic supplementation on hormonal profiles, biomarkers of inflammation and oxidative stress in women with polycystic ovary syndrome: a randomized, double blind, placebo-controlled trial. Arch Iran Med 21(1):1–7PubMed Karamali M, Eghbalpour S, Rajabi S, Jamilian M et al (2018) Effects of probiotic supplementation on hormonal profiles, biomarkers of inflammation and oxidative stress in women with polycystic ovary syndrome: a randomized, double blind, placebo-controlled trial. Arch Iran Med 21(1):1–7PubMed
36.
Zurück zum Zitat Ghanei N, Rezaei N, Amiri GA, Zayeri F, Makki G, Nasseri E (2018) The probiotic supplementation reduced inflammation in polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial. J Funct Food 42:306–311 Ghanei N, Rezaei N, Amiri GA, Zayeri F, Makki G, Nasseri E (2018) The probiotic supplementation reduced inflammation in polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial. J Funct Food 42:306–311
37.
Zurück zum Zitat Gholizadeh-Shamasbi S, Dehgan P, Mohammad-Alizadeh S, Aliasgarzadeh A, Mirghafourvand M (2018) The effect of resistant dextrin as a prebiotic on metabolic parameters and androgen level in women with polycystic ovarian syndrome: a randomized, triple-blind, controlled, clinical trial. Euro J Nutr. https://doi.org/10.1007/s00394-018-1648-7 CrossRef Gholizadeh-Shamasbi S, Dehgan P, Mohammad-Alizadeh S, Aliasgarzadeh A, Mirghafourvand M (2018) The effect of resistant dextrin as a prebiotic on metabolic parameters and androgen level in women with polycystic ovarian syndrome: a randomized, triple-blind, controlled, clinical trial. Euro J Nutr. https://​doi.​org/​10.​1007/​s00394-018-1648-7 CrossRef
41.
Zurück zum Zitat Higgins JPT, Green S (2011) Cochrane handbook for systematic reviews of interventions version 5.1.0. Wiley, Chichester Higgins JPT, Green S (2011) Cochrane handbook for systematic reviews of interventions version 5.1.0. Wiley, Chichester
43.
Zurück zum Zitat Karimi E, Moini A, Yaseri M, Shirzad N, Sepidarkish M, Hossein-Boroujerdi M, Hosseinzadeh-Attar MJ (2018) Effects of synbiotics supplementation on metabolic parameters and apelin in women with polycystic ovary syndrome: a randomised double-blind placebo-controlled trial. Br J Nutr 119(4):398–406. https://doi.org/10.1017/S0007114517003920 CrossRefPubMed Karimi E, Moini A, Yaseri M, Shirzad N, Sepidarkish M, Hossein-Boroujerdi M, Hosseinzadeh-Attar MJ (2018) Effects of synbiotics supplementation on metabolic parameters and apelin in women with polycystic ovary syndrome: a randomised double-blind placebo-controlled trial. Br J Nutr 119(4):398–406. https://​doi.​org/​10.​1017/​S000711451700392​0 CrossRefPubMed
44.
Zurück zum Zitat Ahmadi Sh, Jamilian M, Karamali M, TajabadiEbrahimi M, Jafari P, Taghizadeh M, Memarzadeh MR, Asemi Z (2017) Probiotic supplementation and the effects on weight loss, glycaemia and lipid profiles in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial. Hum Fertil 20(4):254–261. https://doi.org/10.1080/14647273.2017.1283446 CrossRef Ahmadi Sh, Jamilian M, Karamali M, TajabadiEbrahimi M, Jafari P, Taghizadeh M, Memarzadeh MR, Asemi Z (2017) Probiotic supplementation and the effects on weight loss, glycaemia and lipid profiles in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial. Hum Fertil 20(4):254–261. https://​doi.​org/​10.​1080/​14647273.​2017.​1283446 CrossRef
46.
Zurück zum Zitat Shabani A, Noshadian M, Jamilian M, Chamani M, Mohammadi S, Asemi Z (2018) The effects of a novel combination of selenium and probiotic on weight loss, glycemic control and markers of cardio-metabolic risk in women with polycystic ovary syndrome. J Funct Foods 46:329–334 Shabani A, Noshadian M, Jamilian M, Chamani M, Mohammadi S, Asemi Z (2018) The effects of a novel combination of selenium and probiotic on weight loss, glycemic control and markers of cardio-metabolic risk in women with polycystic ovary syndrome. J Funct Foods 46:329–334
47.
Zurück zum Zitat Rashad NM, El-Shal AS, Amin AI, Soliman MH (2017) Effects of probiotics supplementation on macrophage migration inhibitory factor and clinical laboratory feature of polycystic ovary syndrome. J Funct Foods 36:317–324 Rashad NM, El-Shal AS, Amin AI, Soliman MH (2017) Effects of probiotics supplementation on macrophage migration inhibitory factor and clinical laboratory feature of polycystic ovary syndrome. J Funct Foods 36:317–324
48.
Zurück zum Zitat Gholizadeh-Shamasbi S, Dehgan P, Mohammad-Alizadeh S, Aliasgarzadeh A, Mirghafourvand M (2018) Effect of prebiotic on anthropometric indices in women with polycystic ovarian syndrome: a triple-blind, randomized, controlled clinical trial. Iran Red Crescent Med J 20(11):67270 Gholizadeh-Shamasbi S, Dehgan P, Mohammad-Alizadeh S, Aliasgarzadeh A, Mirghafourvand M (2018) Effect of prebiotic on anthropometric indices in women with polycystic ovarian syndrome: a triple-blind, randomized, controlled clinical trial. Iran Red Crescent Med J 20(11):67270
50.
Zurück zum Zitat Khajebishak Y, Payahoo L, Homayouni Rad A, Shokrvash B (2014) The role of intestinal microbiota in health and a short review on the probiotic and prebiotic supplements in obesity prevention. Arak Med Univ J 17(90):18–26 Khajebishak Y, Payahoo L, Homayouni Rad A, Shokrvash B (2014) The role of intestinal microbiota in health and a short review on the probiotic and prebiotic supplements in obesity prevention. Arak Med Univ J 17(90):18–26
51.
Zurück zum Zitat Pan C, Zhao Y, Liao SF, Chen F, Qin S, Wu X et al (2011) Effect of selenium enriched probiotics on laying performance, egg quality, egg selenium content, and egg glutathione peroxidase activity. J Agric Food Chem 59(21):11424–11431PubMed Pan C, Zhao Y, Liao SF, Chen F, Qin S, Wu X et al (2011) Effect of selenium enriched probiotics on laying performance, egg quality, egg selenium content, and egg glutathione peroxidase activity. J Agric Food Chem 59(21):11424–11431PubMed
52.
Zurück zum Zitat Aliasgharzadeh A, Khalili M, Mirtaheri E, Pourghassem Gargari B, Tavakoli F, Abbasalizadeh Farhangi M et al (2015) A combination of prebiotic inulin and oligofructose improve some of cardiovascular disease risk factors in women with type 2 diabetes: a randomized controlled clinical trial. Adv Pharm Bull 5(4):507–514PubMedPubMedCentral Aliasgharzadeh A, Khalili M, Mirtaheri E, Pourghassem Gargari B, Tavakoli F, Abbasalizadeh Farhangi M et al (2015) A combination of prebiotic inulin and oligofructose improve some of cardiovascular disease risk factors in women with type 2 diabetes: a randomized controlled clinical trial. Adv Pharm Bull 5(4):507–514PubMedPubMedCentral
53.
Zurück zum Zitat Amiri M, Golsorkhtabaramiri M, Esmaeilzadeh S, Ghofrani F, Bijani A, Ghorbani L et al (2014) Effect of metformin and flutamide on anthropometric indices and laboratory tests in obese/overweight PCOS women under hypocaloric diet. J Reprod Infertil 15(4):205–213PubMedPubMedCentral Amiri M, Golsorkhtabaramiri M, Esmaeilzadeh S, Ghofrani F, Bijani A, Ghorbani L et al (2014) Effect of metformin and flutamide on anthropometric indices and laboratory tests in obese/overweight PCOS women under hypocaloric diet. J Reprod Infertil 15(4):205–213PubMedPubMedCentral
56.
Zurück zum Zitat Huang A, Brennan K, Azziz R (2010) Prevalence of hyperandrogenemia in the polycystic ovary syndrome diagnosed by the National Institutes of Health 1990 criteria. Fertil Steril 93(6):1938–1941PubMed Huang A, Brennan K, Azziz R (2010) Prevalence of hyperandrogenemia in the polycystic ovary syndrome diagnosed by the National Institutes of Health 1990 criteria. Fertil Steril 93(6):1938–1941PubMed
57.
Zurück zum Zitat Wehr E, Moller R, Horejsi R, Giuliani A, Kopera D, Schweighofer N et al (2009) Subcutaneous adipose tissue topography and metabolic disturbances in polycystic ovary syndrome. Wien Klin Wochenschr 121(7–8):262–269PubMed Wehr E, Moller R, Horejsi R, Giuliani A, Kopera D, Schweighofer N et al (2009) Subcutaneous adipose tissue topography and metabolic disturbances in polycystic ovary syndrome. Wien Klin Wochenschr 121(7–8):262–269PubMed
58.
Zurück zum Zitat West S, Lashen H, Bloigu A, Franks S, Puukka K, Ruokonen A et al (2014) Irregular menstruation and hyperandrogenaemia in adolescence are associated with polycystic ovary syndrome and infertility in later life: northern Finland birth cohort 1986 study. Hum Reprod 29(10):2339–2351PubMedPubMedCentral West S, Lashen H, Bloigu A, Franks S, Puukka K, Ruokonen A et al (2014) Irregular menstruation and hyperandrogenaemia in adolescence are associated with polycystic ovary syndrome and infertility in later life: northern Finland birth cohort 1986 study. Hum Reprod 29(10):2339–2351PubMedPubMedCentral
59.
Zurück zum Zitat Gonzalez F (2015) Nutrient-induced inflammation in polycystic ovary syndrome: role in the development of metabolic aberration and ovarian dysfunction. Semin Reprod Med 33(4):276–286PubMed Gonzalez F (2015) Nutrient-induced inflammation in polycystic ovary syndrome: role in the development of metabolic aberration and ovarian dysfunction. Semin Reprod Med 33(4):276–286PubMed
60.
Zurück zum Zitat Zuo T, Zhu M, Xu W (2016) Roles of oxidative stress in polycystic ovary syndrome and cancers. Oxid Med Cell Longev 2016:8589318PubMed Zuo T, Zhu M, Xu W (2016) Roles of oxidative stress in polycystic ovary syndrome and cancers. Oxid Med Cell Longev 2016:8589318PubMed
61.
Zurück zum Zitat Sathyapalan T, Shepherd J, Coady AM, Kilpatrick ES, Atkin SL (2012) Atorvastatin reduces malondialdehyde concentrations in patients with polycystic ovary syndrome. J Clin Endocrinol Metab 97(11):3951–3955PubMed Sathyapalan T, Shepherd J, Coady AM, Kilpatrick ES, Atkin SL (2012) Atorvastatin reduces malondialdehyde concentrations in patients with polycystic ovary syndrome. J Clin Endocrinol Metab 97(11):3951–3955PubMed
62.
Zurück zum Zitat Diamanti-Kandarakis E, Paterakis T, Alexandraki K, Piperi C, Aessopos A, Katsikis I et al (2006) Indices of low-grade chronic inflammation in polycystic ovary syndrome and the beneficial effect of metformin. Hum Reprod 21(6):1426–1431PubMed Diamanti-Kandarakis E, Paterakis T, Alexandraki K, Piperi C, Aessopos A, Katsikis I et al (2006) Indices of low-grade chronic inflammation in polycystic ovary syndrome and the beneficial effect of metformin. Hum Reprod 21(6):1426–1431PubMed
64.
Zurück zum Zitat Szkudelski T (2001) The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas. Physiol Res 50:537–546PubMed Szkudelski T (2001) The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas. Physiol Res 50:537–546PubMed
65.
Zurück zum Zitat Shakeri H, Hadaegh H, Abedi F et al (2014) Consumption of synbiotics bread decreases triacylglycerol and VLDL levels while increasing HDL levels in serum from patients with type 2 diabetes. Lipids 49(7):695–701PubMed Shakeri H, Hadaegh H, Abedi F et al (2014) Consumption of synbiotics bread decreases triacylglycerol and VLDL levels while increasing HDL levels in serum from patients with type 2 diabetes. Lipids 49(7):695–701PubMed
66.
Zurück zum Zitat Wang Y, Li Y, Xie J et al (2013) Protective effects of probiotic lactobacillus casei Zhang against endotoxin- and d-galactosamine-induced liver injury in rats via anti-oxidative and anti-inflammatory capacities. Int Immunopharmacol 15(1):30–37PubMed Wang Y, Li Y, Xie J et al (2013) Protective effects of probiotic lactobacillus casei Zhang against endotoxin- and d-galactosamine-induced liver injury in rats via anti-oxidative and anti-inflammatory capacities. Int Immunopharmacol 15(1):30–37PubMed
69.
Zurück zum Zitat Cani PD, Possemiers S, Van de Wiele T et al (2009) Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability. Gut 58(8):1091–1103PubMedPubMedCentral Cani PD, Possemiers S, Van de Wiele T et al (2009) Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability. Gut 58(8):1091–1103PubMedPubMedCentral
70.
Zurück zum Zitat Suzuki A, Mitsuyama K, Koga H et al (2006) Bifidogenic growth stimulator for the treatment of active ulcerative colitis: a pilot study. Nutrition 22(1):76–81PubMed Suzuki A, Mitsuyama K, Koga H et al (2006) Bifidogenic growth stimulator for the treatment of active ulcerative colitis: a pilot study. Nutrition 22(1):76–81PubMed
71.
Zurück zum Zitat Rishi P, Mavi SK, Bharrhan S et al (2009) Protective efficacy of probiotic alone or in conjunction with a prebiotic in Salmonella-induced liver damage. FEMS Microbiol Ecol 69(2):222–230PubMed Rishi P, Mavi SK, Bharrhan S et al (2009) Protective efficacy of probiotic alone or in conjunction with a prebiotic in Salmonella-induced liver damage. FEMS Microbiol Ecol 69(2):222–230PubMed
72.
Zurück zum Zitat Heshmati J, Farsi F, Yosaee S, Razavi M, Rezaeinejad M, Karimie E, Sepidarkish M (2018) The effects of probiotics or synbiotics supplementation in women with polycystic ovarian syndrome: a systematic review and meta-analysis of randomized clinical trials. Probiot Antimicro Prot. https://doi.org/10.1007/s12602-018-9493-9 CrossRef Heshmati J, Farsi F, Yosaee S, Razavi M, Rezaeinejad M, Karimie E, Sepidarkish M (2018) The effects of probiotics or synbiotics supplementation in women with polycystic ovarian syndrome: a systematic review and meta-analysis of randomized clinical trials. Probiot Antimicro Prot. https://​doi.​org/​10.​1007/​s12602-018-9493-9 CrossRef
Metadaten
Titel
The effect of probiotics, prebiotics, and synbiotics on hormonal and inflammatory indices in women with polycystic ovary syndrome: a systematic review and meta-analysis
verfasst von
Sevda Gholizadeh Shamasbi
Solmaz Ghanbari-Homayi
Mojgan Mirghafourvand
Publikationsdatum
29.06.2019
Verlag
Springer Berlin Heidelberg
Erschienen in
European Journal of Nutrition / Ausgabe 2/2020
Print ISSN: 1436-6207
Elektronische ISSN: 1436-6215
DOI
https://doi.org/10.1007/s00394-019-02033-1

Weitere Artikel der Ausgabe 2/2020

European Journal of Nutrition 2/2020 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.